Dietary diversity, not broad diet quality score, tracked with lower breast cancer odds
A case-control analysis in women with breast cancer found a clear separation between two dietary measures: dietary diversity score was inversely associated with cancer odds, while the alternative healthy eating index-2010 was not. The study enrolled 477 pathologically confirmed cases and 506 age-matched controls, then assessed diet with a food frequency questionnaire and constructed both indices using standard methods. After adjustment for potential confounders, women in the highest tertile of dietary diversity had 37% lower odds of breast cancer than those in the lowest tertile, with an odds ratio of 0.63 and a 95% confidence interval of 0.42 to 0.95.
A single nutritional score did not capture the same pattern.
Postmenopausal women carried the strongest signal
The association sharpened in postmenopausal women, where the highest tertile of dietary diversity was linked to 60% lower odds of breast cancer compared with the lowest tertile, with an odds ratio of 0.40 and a 95% confidence interval of 0.19 to 0.83 after confounder control. The premenopausal subgroup did not produce the same clear result. This split matters biologically because postmenopausal breast cancer risk is more tightly tied to adiposity, insulin signaling, inflammation, and hormonal milieu, all of which can be influenced by overall food variety and the balance of plant-based and minimally processed foods in the diet.
The Alternative Healthy Eating Index-2010 did not show a significant association with breast cancer odds before or after adjustment, and the null result held in both premenopausal and postmenopausal strata. In practical terms, a composite score built around conventional healthy-eating principles did not perform the way dietary diversity did in this dataset. The contrast suggests that breadth of intake, not just adherence to a predefined quality template, may matter in this population.
Why diet variety may matter in breast carcinogenesis
Dietary diversity is not a proxy for indulgence; it often reflects a wider range of nutrient sources, fiber exposure, phytochemicals, and micronutrients. In a cancer context, that breadth can influence oxidative stress, chronic low-grade inflammation, and metabolic regulation, all of which participate in tumor initiation and promotion. More varied diets may also be less likely to depend on one dominant food pattern that is either highly refined or monotonous in nutrient composition. For breast tissue, where endocrine signaling and metabolic status interact closely, those shifts could plausibly affect risk over time.
The index used here is still an epidemiologic tool, not a biological assay. It cannot isolate which foods or dietary clusters are doing the work, and it cannot prove causation. Yet the divergence between the two dietary measures is informative: if a broad healthy-eating score is null while diversity remains associated with lower odds, the pattern suggests that food variety itself may be capturing exposure dimensions missed by the alternative healthy eating framework.
Case-control design gives association, not prediction
This was a case-control study, so it is designed to compare prior dietary patterns between women with and without disease rather than estimate future incidence. Recall bias is an unavoidable concern with food frequency questionnaires, especially when participants are asked to reconstruct habitual intake. Residual confounding can also linger even after statistical adjustment, particularly for factors that cluster with diet such as physical activity, body composition, reproductive history, socioeconomic status, and screening behavior. Those limitations do not erase the finding, but they do constrain how far it can be carried into clinical advice.
The result is strongest as a hypothesis-generating signal. It supports the idea that dietary pattern research in breast cancer may need to move beyond single nutrients and simple “healthy” scores toward measures that better capture the structural diversity of the diet itself. In a disease with multiple etiologic pathways, a single index may be too blunt to detect every meaningful nutritional relationship.
What the null AHEI result says about diet scoring
The absence of an association for alternative healthy eating index-2010 is just as important as the positive dietary diversity signal. Scores such as AHEI are useful because they summarize dietary quality in a standardized way, but they also compress a complex exposure into a narrower construct. A person can score relatively well on a health-oriented diet index while still eating from a limited range of foods. Conversely, a diet with greater diversity may introduce protective components not fully reflected in a standard score.
For breast cancer prevention research, that distinction is clinically relevant. It argues for broader dietary assessment, especially in populations where meal patterns, food availability, and cultural eating habits shape intake in ways that may not map neatly onto Western dietary scoring systems. It also suggests that future work should compare dietary diversity against multiple pattern-based indices, not just one, and should test whether the signal persists in prospective cohorts with repeated dietary measurement.
The next questions are mechanistic and prospective
The study leaves several questions open. Which food groups contributed most to the diversity signal? Did the association reflect plant foods, dairy, protein sources, or overall nutrient balance? Would the same pattern hold in other populations, different age groups, or women with different baseline metabolic risk? None of those questions can be answered from the present dataset, but each one matters before dietary diversity is translated into prevention messaging.
For now, the cleanest reading is narrow: higher dietary diversity score was associated with lower odds of breast cancer, especially after menopause, while AHEI-2010 was not. The finding is useful because it separates two ways of describing diet and shows that they do not always point in the same direction. Breast cancer epidemiology has plenty of broad statements already; this analysis adds a more specific one, and it will need prospective confirmation before it can be turned into firm dietary guidance.